
Check out Investor Copilot custom GPT, which lets you enjoy ChatGPT functionality with recent financial information
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Historical Deciles for [ASND] Ascendis Pharma A/S
Data updated 2025-Apr-30 (Wednesday)Compare current performance/technical metrics to history for Ascendis Pharma A/S. Range of values presented below in deciles puts current values into historical context (Up to 5-years)
Provided As-is for informational/educational purposes only and should not be construed as investment advice . Past performance may not be not indicative of future results. Always consult your Investment Adviser before any decision
Share
Use widget to view Historical Metric Deciles for other Stocks/ETFs/Indices
Summary 2025-Apr-30 Wednesday
Day Change | +2.32% Top | Day Volatility | 4.32% Mid |
Streak | ↑ 5 days Top | % Streak | +7.78% Top |
RSI | 66 Top | CCI | 121.7 Top |
MACD | 1.59 Top | ATR | 8.21 Top |
ADX | 17.1 Mid | SSO | 93.7 Top |
Change | Volatility | % off SMA | |
---|---|---|---|
5-day | +7.78% Top | 10.16% Mid | +3.11% Top |
10-day | +10.73% Top | 12.67% Mid | +4.69% Top |
20-day | +12.55% Top | 38.11% Top | +10.24% Top |
50-day | +9.12% Mid | 38.11% Mid | +9.95% Top |
100-day | +29.76% Top | 45.17% Mid | +18.49% Top |
200-day | +23.44% Mid | 54.24% Low | +23.29% Top |
Choose Metric type
Select Performance timeframe above to analyze
On 2025-Apr-30, Ascendis Pharma A/S had:daily change of +2.32% intraday volatility of 4.3% 5 ↑(up) day streak yielding +7.78% See how this compares to historical ranges below. Upto last 5 years are bucketed into deciles (click on chart line for details) with 2025-Apr-30 value annotated for comparison
Related to Ascendis Pharma A/S
Information for Ascendis Pharma A/S
Current Detail : Recent daily/monthly performance & benchmark comparison
Historical Detail : Historical performance & related information using Time Machine
Financial Statements : Analyze Income Statement, Balance Sheet & Cashflow Statement and also compare with peers
Bayesian Statement Classifier : Investigate historical financial statements to make probabalistic predictions using Artificial Intelligence
Anomaly Detection : Investigate unusual recent performance & technicals with historical context using AI
Historical Seasonality : Seasonal performance by calendar months
Technical History : Popular Technical indicator trends (RSI, MACD etc.)
Metric Deciles : Contextualizing recent performance & technical levels into historical decile buckets Currently Viewing
Dollar Cost Averaging : Dollar Cost Average (DCA) over time in your portfolio
Moving Averages : Key Simple & Exponential Moving Averages
Historical Analogues : Insights from closest historical matches to recent performance using Artificial Intelligence
Chart Pattern Matching : Insights from similar historical charts to recent chart using Artificial Intelligence
News Stories : News stories on 2025-May-30 on Google
SEC Reports : Quarterly reports around 2025-May-30 on SEC Edgar
Compare Ascendis Pharma A/S with other assets
Market Performance : Recent performance across covered assets
Historical Performance : Prior & Subsequent performance across assets on a historical date
Market Technicals : Technical indicator levels across covered assets
Market Seasonality : Seasonal performance by calendar months across covered assets
Pair Correlations : Performance Correlations with other assets
Beta : Volatility relative to the broad market
Performance Comparison : Visually compare/benchmark performance with other assets over time
Side-by-Side Comparison : Contrast with other assets over time in a side-by-side presentation
Sector : Health Care sector performance which includes Ascendis Pharma A/S
Industry : Pharmaceuticals industry performance which includes Ascendis Pharma A/S